US 8299040
Methods for treating cancer targeting transglutaminase
granted A61KA61K48/00A61P
Quick answer
US patent 8299040 (Methods for treating cancer targeting transglutaminase) held by The Board of Regents of the University of Texas System expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K48/00, A61P, A61P31/00